PCN activation of PXR can protect DSS-induced colitis that is due to the activation of phase II enzymes and efflux transporters (e.g., GSTa1, MDR1a and MRP2), which can reduce the proinflammatory cytokines IL-6, TNF-α, MCP-1, and IL-1α expression. The gene discussed is CCL2; the disease is colitis.